Back to search

Article

A20 is an immune tolerance factor that can determine islet transplant outcomes

2019-09-16

Abstract excerpt

Islet transplantation can restore lost glycemic control in type 1 diabetes subjects, but is restricted in its clinical application by limiting supplies of islets and the need for heavy immune suppression to prevent rejection. TNFAIP3 , encoding the ubiquitin editing enzyme A20, regulates the activation of immune cells by raising NF-κB signalling thresholds. Here we show that increasing A20 expression in allogenei...

Topics

Open a Topic to create a Post that cites this publication.

Identifiers and source

Literature Corpus work
86a78189-72df-5677-b75d-dcbd5bae0198
DOI
10.1101/770834
Open publication

Related research

Semantic proximity does not establish scientific evidence.

Click a neighbor to travelStep 1 · 12 closest
Interactive article relationship graphSelect a related publication card to move it into the centre and load its closest explainable connections. Solid lines are source-backed structured connections. Dashed lines are semantic discovery signals and are not scientific evidence.
A20 is an immune tolerance factor that can determine islet transplant outcomesDOI 10.1101/770834
Select a neighboring publication to make it the new centre.